Market Tracker

08/24 12:35pm ET

Lannett Company Inc (NYSE:LCI)

37.26
BATS BZX Real-Time Price
As of 12:10pm ET
 +4.94 / +15.28%
Today’s Change
16.91
Today|||52-Week Range
60.45
-7.13%
Year-to-Date
Stocks Look Lackluster as Markets Await Yellen
10:51am / TheStreet.com - Paid Partner Content
Lannett (LCI) Stock Jumps as Q4 Earnings, Revenue Beat Estimates
10:18am / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close32.32
Today’s open37.15
Day’s range36.78 - 39.94
Volume223,652
Average volume (3 months)788,621
Market cap$1.2B
Dividend yield--
Data as of 12:10pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)+149.38%
Earnings growth (this year)-17.33%
Earnings growth (next 5 years)+184.00%
Revenue growth (last year)+48.60%
P/E ratio18.6
Price/Sales5.42
Price/Book2.53

Competitors

 Today’s
change
Today’s
% change
CEMPCempra Inc+0.37+1.62%
ACORAcorda Therapeutics ...+0.10+0.39%
DERMDermira Inc+0.88+2.58%
INSYINSYS Therapeutics I...+1.31+8.00%
Data as of 12:11pm ET, 08/24/2016

Financials

Last reporting dateAugust 24, 2016
EPS forecast (this quarter)$0.60
Annual revenue (last year)$406.8M
Annual profit (last year)$149.9M
Net profit margin36.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Arthur P. Bedrosian
CFO, Treasurer &
Vice President-Finance
Martin P. Galvan
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts